Firm

Levin Firm Wins $140 Million Award in Medication Lawsuit

The Levin, Papantonio, Mitchell, Rafferty & Proctor law firm in Pensacola has won more than $140 million in damages for a man who blamed his heart attack on a medication. According to the Levin firm, Jeffrey Konrad of Memphis, Tennessee, used the testosterone replacement therapy AndroGel. His legal team, including Troy Rafferty of the Levin firm, argued that the manufacturer, AbbVie, …


OMEGA (OME) Alert: Johnson Fistel Investigates Proposed Sale of Omega Protein Corporation; Are Shareholders Getting a Fair Price?

Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Omega Protein Corporation (NYSE: OME) (“Omega Protein”) breached their fiduciary duties in connection with the proposed sale of the Company to Cooke Inc. Omega Protein develops, produces, and delivers products to enhance the nutritional integrity of foods, dietary supplements, and animal feeds worldwide.


INVESTOR ALERT: Kirby McInerney LLP Commences Class Action on Behalf of Frontier Communications Corporation Investors

Kirby McInerney LLP announced today a class action lawsuit on behalf of investors who purchased Frontier Communications Corporation (“Frontier” or the “Company”) (NASDAQ:FTR) securities between April 1, 2016, and May 2, 2017 (the “Class Period”). Frontier investors have until November 27, 2017 to file a lead plaintiff motion. To obtain information or participate in the class action, please visit the Frontier page on our website at www.kmllp.com.


County May Join Opioid Lawsuit

St. Lawrence County legislators have agreed to meet with an attorney about the possibility of joining a class action lawsuit against companies that manufacture opioids. County Attorney Stephen D. Button said several months ago he was contacted by several firms involved in large-scale, multi-defendant opioid litigation. “They were interested in gauging the county’s interest in pursuing …


Uber’s Kalanick Calls Benchmark Lawsuit a ‘Fabrication’

Uber’s co-founder Travis Kalanick fired back at investor Benchmark, saying its lawsuit seeking to oust him from the ride-hailing company’s board is based on “a fabrication” and accused the firm of threats and intimidation. Upping the ante on his fight with the venture capital firm, which holds a 13% stake in Uber, Kalanick said that Benchmark waged a secret campaign to remove him …


New Lawsuit Claims Fyre Festival Is ‘massive Ponzi Scheme’

A new lawsuit filed against the organizers of the disastrous Fyre Festival accuses them of staging “a massive Ponzi scheme.” New paperwork in a class-action lawsuit filed by LA lawyer Mark Geragos describes the festival as “a get rich quick scheme” and indicates that he is investigating “Seed Series” investors to find out if they were also defrauded or were in on the ruse. Page Six can reveal …


Fyre Festival $100 Million Lawsuit Targets Investors Behind the Scenes

Before the now-infamous Fyre Festival collapsed a few weeks back, the company behind it—maker of a mobile phone app you can use to hire entertainers for your club, concert, or party—said it was worth $90 million, according to a document obtained by Bloomberg News. Fyre Media Inc. faces a half-dozen lawsuits from less-than-satisfied customers over the disastrous music event in the Bahamas. Now …


Ocwen Financial Corporation Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Possible Breaches of Fiduciary Duty by Officers and Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed against Ocwen Financial Corporation (“Ocwen” or “Company”) (OCN) and several officers and directors for acts taken during the period of May 11, 2015 and April 19, 2017 (the “Class Period”). …



SHAREHOLDER ALERT:  Pomerantz Law Firm Announces the Filing of a Class Action Against Lion Biotechnologies, Inc. And Certain Officers – LBIO

Pomerantz LLP announces that a class action lawsuit has been filed against Lion Biotechnologies, Inc. (“Lion” or the “Company”) (NASDAQ:LBIO) and certain of its officers. The class action, filed in United States District Court, Northern District of California, and docketed under 17-cv-02188 is on behalf of a class consisting of investors who purchased or otherwise …